Our Story
Shaping the Future of Liquid Biopsy-Based Cancer Detection and Monitoring
About Us
About ExoCellular Diagnostics Inc.
ExoCellular Diagnostics Inc., is a privately held company commercializing liquid biopsy-based cancer diagnostic tests. The Company is headquartered in Cambridge, Massachusetts, USA, and has facilities in Munich, Germany. We focus on the development and commercialization of novel liquid biopsy-based tests for cancer detection and disease monitoring.
Get Started with ExoCellular Diagnostics
Join us in transforming the world of cancer diagnostics. Contact us today to learn more about our innovative liquid biopsy tests.